InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.000
-0.070 (-6.54%)
Jan 15, 2026, 4:00 PM EST - Market closed
InflaRx Market Cap
InflaRx has a market cap or net worth of $67.75 million as of January 16, 2026. Its market cap has decreased by -56.43% in one year.
Market Cap
67.75M
Enterprise Value
16.82M
1-Year Change
-56.43%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $67.75M, a decrease of -80.69%. That is a compound annual growth rate of -18.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 67.70M | -1.02% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |